421-83-0

Applied Filters:

Keyword:'421-83-0'

Showing 1-1 of 1 result for "421-83-0" within Papers

Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.

Angel Chamorro et al.

The Lancet. Neurology, 13(5), 453-460 (2014-04-08)

Uric acid is an antioxidant with neuroprotective effects in experimental models of stroke. We assessed whether uric acid therapy would improve functional outcomes at 90 days in patients with acute ischaemic stroke. URICO-ICTUS was a randomised, double-blind, placebo-controlled, phase 2b/3

Page 1 of 1